NIPAL4

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, NIPAL4 mutation is significantly associated with the drug of many other genes, with 47 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible NIPAL4-associated genes across cancer lineages are Mirin, 150412, and GW-2580. Each is linked with NIPAL4 in more than 1 cancer types. Because this analysis shows association rather than direction, both NIPAL4-to-partner and partner-to-NIPAL4 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Mirin grouped by NIPAL4-low versus NIPAL4-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NIPAL4→partner) and Y-score (partner→NIPAL4) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEMirin →+0.414+2.868.020.02231
LARGE_INTESTINE150412 →+0.426+3.000.006.01722
LARGE_INTESTINEGW-2580 →+0.383+2.786.002.03731
LARGE_INTESTINEBX-912 →+0.685+2.652.018.04531
LARGE_INTESTINEQuizartinib →+0.467+2.652.003.04531
LARGE_INTESTINESelisistat →+0.270+2.652.006.04531
Each partner links to its Q-omics profile. Showing the 6 strongest of 47 associations by consensus.

Mirin by NIPAL4 expression — LARGE_INTESTINE

Box plot of Mirin in NIPAL4-low vs NIPAL4-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration